Molecular genetic abnormalities in the pathogenesis of human lung cancer
- 1 March 2001
- journal article
- review article
- Published by Springer Nature in Pathology and Oncology Research
- Vol. 7 (1) , 6-13
- https://doi.org/10.1007/bf03032598
Abstract
In the past few years our knowledge of the molecular pathogenesis of lung cancer has significantly increased. There are several molecular mechanisms involved in the multistage carcinogenesis through which respiratory epithelial cells become preneoplastic and then invasive cancer. In this review we summarize some of these changes including, genomic alterations such as loss of heterozygosity and microsatellite alterations, autocrine-paracrine loops, alterations in oncogenes and tumor suppressor genes, tumor angiogenesis, aberrant promoter methylation and inherited predisposition to lung cancer. Translation of these findings to the clinic is also discussed.Keywords
This publication has 102 references indexed in Scilit:
- Lung Cancer HighlightsThe Oncologist, 2000
- Promoter Methylation and Silencing of the Retinoic Acid Receptor- Gene in Lung CarcinomasJNCI Journal of the National Cancer Institute, 2000
- Tobacco Smoke Carcinogens and Lung CancerJNCI Journal of the National Cancer Institute, 1999
- TheDUTT1Gene, a Novel NCAM Family Member Is Expressed in Developing Murine Neural Tissues and Has an Unusually Broad Pattern of ExpressionMolecular and Cellular Neuroscience, 1998
- The Molecular Epidemiology of Lung CancerCritical Reviews in Toxicology, 1997
- CLINICAL IMPLICATIONS OF THE p53 GENEAnnual Review of Medicine, 1996
- Bombesin receptor structure and expression in human lung carcinoma cell linesJournal of Cellular Biochemistry, 1996
- MYC family DNA amplification in 126 tumor cell lines from patients with small cell lung cancerJournal of Cellular Biochemistry, 1996
- bcl-2 Protein in Non-Small-Cell Lung CarcinomaNew England Journal of Medicine, 1993
- Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancerNature, 1985